Nikhil Lalwani, PRESIDENT & CEO at ANI PHARMACEUTICALS INC (ANIP), sold 136,564 shares at $57.75 ($8.0M) on 2023-08-11, disclosed to the SEC on 2023-08-15.
Open-market sale of $8.0M ANIP by PRESIDENT & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.75 | 56,666 | $3.3M | 41.1% |
| 2 | $57.75 | 56,666 | $3.3M | 41.1% |
| 3 | $61.13 | 11,616 | $710K | 8.9% |
| 4 | $61.13 | 11,616 | $710K | 8.9% |
| Total | $58.33 avg | 136,564 | $8.0M | 100% |
| Filing → |
| ANIP | SELL | 2026-08-26 | $401K | — | Filing → |
| ANIP | SELL | 2026-05-13 | $4.3M | — | Filing → |
| ANIP | SELL | 2025-08-14 | $9.8M | — | Filing → |